Fermelanta

Fermelanta, Inc. is a Japan-based synthetic biology and biomanufacturing startup that engineers microbial cell factories to produce rare, high-value plant-derived compounds via precision fermentation. The company's proprietary platform introduces over 20 genes into highly productive E. coli, enabling biosynthesis of complex phytochemicals — including morphine precursors — that are costly or impractical to extract from plants. Fermelanta serves the dietary supplements, functional foods, pharmaceutical, and cosmetics markets with scalable, sustainable alternatives to plant extraction and petrochemical processes.